[By NBC-1TV H. J Yook]Gangwon medical device manufacturer NEO Dr. (CEO: Hyun-Ho Kim) revealed that the company is “advancing full-scale into the Chinese market with the representative product of continuous self-acupuncture device AcuPro and needle cartridges.”

NEO Dr. has completed the development of localized trademark to advance into the Chinese market, and is in progress of authorization and approval for SFDA which is China’s medical device licensing system.

Also, having participated in the 28th International Medical & Hospital Equipment Show (KIMES 2012) held at Seoul Samsung-dong COEX from last February 16th to 19th, NEO Dr. is receiving active support through consultation with the buyer from China.

The Chinese buyer will be submitting the NEO Dr. products on its own to the Beijing Medical Equipment Exhibition to be held on the upcoming 22nd. NEO Dr. headquarters is planning to execute even more active promotion marketing by deploying a team of resources.

The continuous acupuncture device AcuPro of NEO Dr. is a device which makes it convenient to apply the Oriental acupuncture, with almost no pain but being very sanitary. As the needle does not need to be touched during the application, it is effectively protected from external contamination.

Using the single-serving cartridge with many needles, it saves a lot of time, while making the cartridge replacement quite simple and convenient. Especially it does not show the needle before the treatment to reduce the fear of the patient, and the application is very quick to reduce pain. The needles come in various sizes such as Pro60 or Pro70, and is in sterilized packaging for a more sanitary use

Besides, NEO Dr. features various other medical products such as AcuSta, Neo Plunger, ND Needle (NEO, NEO One, Multi, AS50) and such.

CEO Hyun-Ho Kim of NEO Dr. said “as soon as SFDA licensing is completed in the first half of this year, we will go full-scale for the advancement to the Chinese market” and that “based on the Chinese market at this time, we will execute an aggressive overseas marketing.”